Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo‐Controlled Study

OBJECTIVE: To assess the efficacy and safety of febuxostat extended release (XR) and immediate release (IR) in patients with gout and normal or impaired renal function. METHODS: This was a 3‐month, phase III, multicenter, double‐blind, placebo‐controlled study. Patients (n = 1,790) with a history of...

Descripción completa

Detalles Bibliográficos
Autores principales: Saag, Kenneth G., Becker, Michael A., Whelton, Andrew, Hunt, Barbara, Castillo, Majin, Kisfalvi, Krisztina, Gunawardhana, Lhanoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Gout
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590450/
https://www.ncbi.nlm.nih.gov/pubmed/30073793
http://dx.doi.org/10.1002/art.40685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590450/
https://www.ncbi.nlm.nih.gov/pubmed/30073793
http://dx.doi.org/10.1002/art.40685

Ejemplares similares